UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5751
Empery Digital
EMPD
$59.6M
| $932K | ﹤0.01% |
261,824
-265,927
| -50% | -$1.19M |
2024 Q1
9 quarters
|
|
5752
Clean Energy Fuels
CLNE
$421M
| $932K | ﹤0.01% |
454,523
+112,920
| +33% | +$240K |
2014 Q4
46 quarters
|
|
5753
Cerence
CRNC
$369M
| $930K | ﹤0.01% |
82,127
+2,733
| +3% | +$26.8K |
2019 Q4
26 quarters
|
|
5754
PUT
Capri Holdings
CPRI
$2.12B
| $928K | ﹤0.01% |
+50,000
| New | +$960K |
2026 Q2
0 quarters
|
|
5755
CALL
XPeng
XPEV
$9.8B
| $927K | ﹤0.01% |
70,000
-1,797,145
| -96% | -$28.5M |
2024 Q3
7 quarters
|
|
|
5756
PUT
XPeng
XPEV
$9.8B
| $927K | ﹤0.01% |
70,000
-660,000
| -90% | -$10.5M |
2025 Q4
2 quarters
|
|
5757
ECARX Holdings
ECX
$315M
| $926K | ﹤0.01% |
718,091
+35,961
| +5% | +$41K |
2024 Q3
7 quarters
|
|
5758
Horizon Technology Finance
HRZN
$265M
| $925K | ﹤0.01% |
195,466
+51,330
| +36% | +$222K |
2014 Q4
46 quarters
|
|
5759
Voya Global Advantage and Premium Opportunity Fund
IGA
$154M
| $924K | ﹤0.01% |
93,322
-1,914
| -2% | -$18.5K |
2014 Q4
46 quarters
|
|
5760
Forum Markets
FRMM
$40.1M
| $921K | ﹤0.01% |
169,656
-158,138
| -48% | -$691K |
2025 Q2
4 quarters
|
|
5761
Five Star Bancorp
FSBC
$1.08B
| $921K | ﹤0.01% |
18,917
-9,856
| -34% | -$416K |
2021 Q4
18 quarters
|
|
5762
VEON
VEON
$5.34B
| $921K | ﹤0.01% |
17,636
+419
| +2% | +$21.8K |
2014 Q4
46 quarters
|
|
5763
Octave Specialty Group
OSG
$225M
| $919K | ﹤0.01% |
147,197
-117,083
| -44% | -$610K |
2014 Q4
46 quarters
|
|
5764
Barron's 400 ETF
BFOR
$233M
| $918K | ﹤0.01% |
38,404
-2,228
| -5% | -$49.9K |
2014 Q4
46 quarters
|
|
5765
Materialise
MTLS
$385M
| $916K | ﹤0.01% |
123,225
+61,692
| +100% | +$365K |
2014 Q4
46 quarters
|
|
5766
aTyr Pharma
ATYR
$15.9M
| $914K | ﹤0.01% |
38,279
-58,401
| -60% | -$1.53M |
2024 Q4
6 quarters
|
|
5767
Turtle Beach Corp
TBCH
$272M
| $914K | ﹤0.01% |
73,420
+43,698
| +147% | +$518K |
2018 Q1
33 quarters
|
|
5768
Huya Inc
HUYA
$500M
| $914K | ﹤0.01% |
397,309
+38,642
| +11% | +$110K |
2018 Q2
32 quarters
|
|
5769
Calamos Dynamic Convertible & Income Fund
CCD
$573M
| $911K | ﹤0.01% |
35,370
-86,674
| -71% | -$2.12M |
2015 Q1
45 quarters
|
|
5770
Caribou Biosciences
CRBU
$48.1M
| $911K | ﹤0.01% |
517,371
+258,202
| +100% | +$510K |
2021 Q3
19 quarters
|
|
5771
ProShares UltraShort QQQ
QID
$332M
| $910K | ﹤0.01% |
67,157
-9,798
| -13% | -$158K |
2023 Q2
12 quarters
|
|
5772
CALL
Invesco NASDAQ 100 ETF
QQQM
$100B
| $909K | ﹤0.01% |
3,000
-510
| -15% | -$144K |
2026 Q1
1 quarter
|
|
5773
The Honest Company
HNST
$501M
| $909K | ﹤0.01% |
248,333
-455,748
| -65% | -$1.54M |
2023 Q4
10 quarters
|
|
5774
MiMedx Group
MDXG
$483M
| $909K | ﹤0.01% |
236,033
-436,969
| -65% | -$1.59M |
2020 Q4
22 quarters
|
|
5775
BrightSpring Health Services Unit
BTSGU
$1.7B
| $908K | ﹤0.01% |
3,967
+623
| +19% | +$114K |
2025 Q2
4 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.